These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 17803655)
1. PIK3CA mutation and amplification in human lung cancer. Okudela K; Suzuki M; Kageyama S; Bunai T; Nagura K; Igarashi H; Takamochi K; Suzuki K; Yamada T; Niwa H; Ohashi R; Ogawa H; Mori H; Kitamura H; Kaneko T; Tsuneyoshi T; Sugimura H Pathol Int; 2007 Oct; 57(10):664-71. PubMed ID: 17803655 [TBL] [Abstract][Full Text] [Related]
2. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma. Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376 [TBL] [Abstract][Full Text] [Related]
3. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas. Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548 [TBL] [Abstract][Full Text] [Related]
4. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue. Estilo CL; O-Charoenrat P; Ngai I; Patel SG; Reddy PG; Dao S; Shaha AR; Kraus DH; Boyle JO; Wong RJ; Pfister DG; Huryn JM; Zlotolow IM; Shah JP; Singh B Clin Cancer Res; 2003 Jun; 9(6):2300-6. PubMed ID: 12796399 [TBL] [Abstract][Full Text] [Related]
5. PIK3CA gene amplification in Japanese non-small cell lung cancer. Kawano O; Sasaki H; Okuda K; Yukiue H; Yokoyama T; Yano M; Fujii Y Lung Cancer; 2007 Oct; 58(1):159-60. PubMed ID: 17681398 [TBL] [Abstract][Full Text] [Related]
6. ERBB2 kinase domain mutation in the lung squamous cell carcinoma. Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Wang YP; Jo KH; Moon SW; Song SY; Lee JY; Yoo NJ; Lee SH Cancer Lett; 2006 Jun; 237(1):89-94. PubMed ID: 16029927 [TBL] [Abstract][Full Text] [Related]
7. Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer. Jehan Z; Bavi P; Sultana M; Abubaker J; Bu R; Hussain A; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS J Pathol; 2009 Nov; 219(3):337-46. PubMed ID: 19697359 [TBL] [Abstract][Full Text] [Related]
8. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410 [TBL] [Abstract][Full Text] [Related]
9. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. Woenckhaus J; Steger K; Werner E; Fenic I; Gamerdinger U; Dreyer T; Stahl U J Pathol; 2002 Nov; 198(3):335-42. PubMed ID: 12375266 [TBL] [Abstract][Full Text] [Related]
10. Defective expression of transforming growth factor beta type II receptor (TGFBR2) in the large cell variant of non-small cell lung carcinoma. Xu JB; Bao Y; Liu X; Liu Y; Huang S; Wang JC Lung Cancer; 2007 Oct; 58(1):36-43. PubMed ID: 17566598 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women. Maruyama N; Miyoshi Y; Taguchi T; Tamaki Y; Monden M; Noguchi S Clin Cancer Res; 2007 Jan; 13(2 Pt 1):408-14. PubMed ID: 17202311 [TBL] [Abstract][Full Text] [Related]
13. Absence of hotspot mutations in exons 9 and 20 of the PIK3CA gene in human oral squamous cell carcinoma in the Greek population. Kostakis GC; Papadogeorgakis N; Koumaki V; Kamakari S; Koumaki D; Alexandridis C Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):e53-8. PubMed ID: 20416519 [TBL] [Abstract][Full Text] [Related]
14. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Massion PP; Kuo WL; Stokoe D; Olshen AB; Treseler PA; Chin K; Chen C; Polikoff D; Jain AN; Pinkel D; Albertson DG; Jablons DM; Gray JW Cancer Res; 2002 Jul; 62(13):3636-40. PubMed ID: 12097266 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer. Shibata T; Kokubu A; Tsuta K; Hirohashi S Cancer Lett; 2009 Oct; 283(2):203-11. PubMed ID: 19394761 [TBL] [Abstract][Full Text] [Related]
16. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites. Maier S; Wilbertz T; Braun M; Scheble V; Reischl M; Mikut R; Menon R; Nikolov P; Petersen K; Beschorner C; Moch H; Kakies C; Protzel C; Bauer J; Soltermann A; Fend F; Staebler A; Lengerke C; Perner S Hum Pathol; 2011 Aug; 42(8):1078-88. PubMed ID: 21334718 [TBL] [Abstract][Full Text] [Related]
17. Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas. Barbareschi M; Buttitta F; Felicioni L; Cotrupi S; Barassi F; Del Grammastro M; Ferro A; Dalla Palma P; Galligioni E; Marchetti A Clin Cancer Res; 2007 Oct; 13(20):6064-9. PubMed ID: 17947469 [TBL] [Abstract][Full Text] [Related]
18. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Lee JW; Soung YH; Kim SY; Lee HW; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH Oncogene; 2005 Feb; 24(8):1477-80. PubMed ID: 15608678 [TBL] [Abstract][Full Text] [Related]
19. PIK3CA gene mutations in breast carcinoma in Malaysian patients. Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487 [TBL] [Abstract][Full Text] [Related]
20. Oncogenic role of JC virus in lung cancer. Zheng H; Abdel Aziz HO; Nakanishi Y; Masuda S; Saito H; Tsuneyama K; Takano Y J Pathol; 2007 Jul; 212(3):306-15. PubMed ID: 17534844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]